2018 Global Impact Award winner announced
The Women’s Bakery, which provides access to education and employment for women in East Africa through the building of bakeries, won Washington University in St. Louis’ 2018 Global Impact Award on Oct. 29.
Applications now open for Global Impact Award
Applications are now open for the 2018 Global Impact Award (GIA), Washington University in St. Louis’ business plan competition for ventures that are scalable, sustainable and quick-to-market with proof of concept and a broad impact. The deadline is noon March 19.
Epharmix wins $50,000 in the 2016 Global Impact Award
Epharmix, a health-care software startup created at Washington University in St. Louis, will receive $50,000 in equity-free funding as the 2016 winner of the Global Impact Award.
Finalists announced for Global Impact Award
Six finalists for the Skandalaris Center’s 3rd annual Global Impact Award have been announced. The startups will compete for a prize of up to $50,000 in funding that will be awarded this November.
Submissions sought for Global Impact Award
The Skandalaris Center for Interdiscplinary Innovation and Entrepreneurship is now accepting submissions for the Global Impact Award. The award supports university students, postdoctoral researchers and young alumni who seek to create entrepreneurial ventures with a global impact.
Global Impact Award winner selected
Now in its second year, the Suren G. Dutia and Jas K. Grewal Global Impact Award is given to Washington University in St. Louis-based entrepreneurs who use technology to solve real-world problems. A total of 19 teams entered this year’s competition, and the winner of the $50,000 prize, announced Nov. 2, is Applied Particle Technology.
Two teams win inaugural Global Impact Award
Nanopore Diagnostics and ViFlex are the inaugural winners of the Suren G. Dutia and Jas K. Grewal Global Impact Award from the Skandalaris Center for Entrepreneurial Studies at Washington University in St. Louis. Tom Cohen (right) and Nanopore are developing a test to better tailor antibiotics, and ViFlex is working on low-cost eyeglasses for developing countries.